Featured Slider

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2024.

EAN Education Committee Chair, Irena Rektorová, looks at 10 years of successful EAN educational projects and highlights some imminent application openings and deadlines.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2024.

Our paper of the month for April is the latest work by the Global Burden of Diseases Collaborator Network, which has found that neurological conditions are the leading cause of ill health and disability worldwide, with over 3.4 billion people worldwide are affected.

EAN President-Elect, Elena Moro shares her plan for the future of neurology and highlights current key events and activities.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2024.

Our Paper of the month for March is a retrospective longitudinal study emphasizing the important role of cortical myelin dynamics in determining neurodegeneration and clinical progression in MS.

EAN President Paul Boon on the new all-time abstract submission record set for EAN 2024, and news of major recent and upcoming events.

Our paper of the month for February is an open-label extension study to assess the long-term efficacy and safety of cerliponase in padiatric patients with CLN2 disease.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2024.

EAN Programme Committee Chair, Ulf Kallweit, provides a preview of the 10th Congress of the European Academy of Neurology, including some great new programme features.

A retrospective, multicentre, cross-sectional study aiming to evaluate the performance of cortical lesions and the central vein sign in differentiating multiple sclerosis from other conditions with brain white matter lesions.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for January 2024.

EAN President Paul Boon takes a look at some of the major EAN events of 2023 and casts an eye over what is to come in 2024, when we will celebrate ten years of the EAN.

This study presents the results of a clinical trial investigating whether apixaban, compared to aspirin, would be associated with reduced risk of stroke or systemic embolism, with a tolerably low risk of major bleeding.